• About
  • Contact
  • Resources
  • Book Nook
Donate
  • Featured
  • Commentary
  • Science & News
  • Mainstream
    • Mainstream Prevention
    • Mainstream Treatment
    • Vaccines
    • Repurposed Drugs
  • Integrative
    • Integrative Prevention
    • Integrative Treatments
    • Integrative Recovery
      • Long Haul
  • Controversies
    • Ivermectin
  • Blog
    • Michael Lerner’s Blog
    • Guest Authors
MenuClose
  • Featured
  • Commentary
  • Science & News
  • Mainstream Solutions
    • Mainstream Prevention
    • Mainstream Treatment
    • Vaccines
    • Repurposed Drugs
  • Integrative Therapies
    • Integrative Prevention
    • Integrative Treatments
    • Integrative Recovery
      • Long Haul
  • Controversies
    • Ivermectin
  • Blog
    • Guest Authors
    • Michael Lerner’s Blog
  • About
  • Contact
  • Resources
  • Donate
 — Article Category —

Ivermectin


Ivermectin Has Little Effect on Recovery Time From Covid, Study Finds

Ivermectin Has Little Effect on Recovery Time From Covid, Study Finds

by Covid Strategies | Jun 12, 2022 | Controversies, Featured, Ivermectin

A new clinical trial is the largest to date testing the antiparasitic drug on people with Covid. By Carl Zimmer The antiparasite drug ivermectin does not meaningfully reduce the time needed to recover from Covid, according to a large study posted online Sunday....

read more
Map of States with Ivermectin Legislation

Map of States with Ivermectin Legislation

by Covid Strategies | Apr 4, 2022 | Controversies, Featured, Ivermectin

Many states in the U.S. have been moving forward with legislation making the “controversial” medication ivermectin available over the counter, allowing physicians to prescribe the drug and pharmacists to dispense the medication without suffering a legal penalty....

read more
Ivermectin Does Not Reduce Risk of Covid Hospitalization, Large Study Finds

Ivermectin Does Not Reduce Risk of Covid Hospitalization, Large Study Finds

by Covid Strategies | Mar 30, 2022 | Controversies, Featured, Ivermectin

“At some point it will become a waste of resources to continue studying an unpromising approach,” one expert said. By Carl Zimmer The anti-parasitic drug ivermectin, which has surged in popularity as an alternative treatment for Covid-19 despite a lack of...

read more
Effect of Early Treatment with Ivermectin among Patients with Covid-19

Effect of Early Treatment with Ivermectin among Patients with Covid-19

by Covid Strategies | Mar 30, 2022 | Controversies, Featured, Ivermectin

By Gilmar Reis, M.D., Ph.D., et al. Abstract BACKGROUND The efficacy of ivermectin in preventing hospitalization or extended observation in an emergency setting among outpatients with acutely symptomatic coronavirus disease 2019 (Covid-19), the disease caused by...

read more
Tennessee Advancing Ivermectin Bills

Tennessee Advancing Ivermectin Bills

by Covid Strategies | Mar 28, 2022 | Controversies, Ivermectin

Tennessee appears to be the latest state moving forward with two bills to allow people to purchase ivermectin as an alternative treatment for COVID-19. One bill, SB 2746, is being proposed by Republican State Representative Susan Lynn, and...

read more
French Biotech Commercializing ivermectin for COVID-19 Treats First Patients in 400 Participant RCT

French Biotech Commercializing ivermectin for COVID-19 Treats First Patients in 400 Participant RCT

by Covid Strategies | Mar 28, 2022 | Controversies, Ivermectin

The French biotech company MedinCell announced it has treated the first participants in the SAIVE study last week, the 400-participant, multicenter, randomized, double-blind, placebo-controlled study with an independent Data Monitoring Committee, conducted...

read more
Ivermectin and COVID: Is a Microscopic Worm the Key?

Ivermectin and COVID: Is a Microscopic Worm the Key?

by Covid Strategies | Mar 22, 2022 | Controversies, Featured, Ivermectin

By F. Perry Wilson, MD, MSCE Welcome to Impact Factor, your weekly dose of commentary on a new medical study. I'm Dr F. Perry Wilson of the Yale School of Medicine If you took a random sample of 100 people from around the world, eight of them would have these...

read more
New Hampshire state House approves bill that would make Ivermectin available over the counter

New Hampshire state House approves bill that would make Ivermectin available over the counter

by Covid Strategies | Mar 17, 2022 | Controversies, Ivermectin

Similar bills are working their way through the legislature in Oklahoma, Missouri, Indiana, Arizona, and Alaska. By Sophie Mann New Hampshire's GOP-led House has passed a bill that would allow pharmacists to dispense Ivermectin under a standard order, meaning...

read more
Mary Beth Pfeiffer is Banned From Twitter

Mary Beth Pfeiffer is Banned From Twitter

by Covid Strategies | Mar 2, 2022 | Controversies, Featured, Ivermectin

By Mary Beth Pfeiffer On Tuesday, March 1, 2022, I received an email from Twitter. It seems I had violated policy “on spreading misleading and potentially harmful information related to COVID-19.” Without ceremony or meaningful due process, Twitter suspended my...

read more
Is Ivermectin a Miracle or a Menace vs COVID?

Is Ivermectin a Miracle or a Menace vs COVID?

by Covid Strategies | Feb 24, 2022 | Controversies, Featured, Ivermectin

Is Ivermectin a miracle or a menace against COVID-19? It's a miracle vs. onchocerciasis. COVID? A new study suggests ivermectin is not great. By Joe Graedon Let me be perfectly honest. I love ivermectin. Is ivermectin a miracle? Absolutely! It has saved the...

read more
The Disinformation Campaign Against Ivermectin – JAMA’s “Diversion”

The Disinformation Campaign Against Ivermectin – JAMA’s “Diversion”

by Covid Strategies | Feb 19, 2022 | Controversies, Featured, Ivermectin

Big Pharma influences high-impact journals to selectively publish (purportedly) negative studies while outright rejecting positive studies from publication. JAMA did it again yesterday. By Pierre Kory, MD, MPA One of the main corporate disinformation tactics used to...

read more
Ivermectin Flops Again for COVID, This Time in High-Risk Adults

Ivermectin Flops Again for COVID, This Time in High-Risk Adults

by Covid Strategies | Feb 18, 2022 | Controversies, Featured, Ivermectin

— Malaysian trial finds no difference in progression to severe disease over standard of care by Molly Walker Ivermectin failed to prevent older adults with COVID-19 from progressing to severe disease compared with standard of care alone, an open-label randomized trial...

read more
Nebraska’s top attorney finds ivermectin, hydroxychloroquine valid COVID-19 treatments

Nebraska’s top attorney finds ivermectin, hydroxychloroquine valid COVID-19 treatments

by Covid Strategies | Feb 18, 2022 | Controversies, Ivermectin

by: George Lauby On Jan. 25, for more than five hours, medical professionals spoke about alternate ways to treat COVID-19 before U.S. Sen. Ron Johnson of Wisconsin. The panelists generally said conventional treatments of COVID-19 ignore, and frequently condemn, some...

read more
Duke doctors testing whether more ivermectin for twice as long will work against COVID-19

Duke doctors testing whether more ivermectin for twice as long will work against COVID-19

by Covid Strategies | Feb 17, 2022 | Controversies, Ivermectin

by: Joedy McCreary  Researchers at Duke want to know if taking more ivermectin for longer will work better as a COVID-19 treatment. A study that is testing three repurposed medications as COVID treatments is expanding to evaluate the polarizing anti-parasitic...

read more
South Dakota Advances Legislation Protecting Ivermectin Prescriptions

South Dakota Advances Legislation Protecting Ivermectin Prescriptions

by Covid Strategies | Feb 16, 2022 | Controversies, Featured, Ivermectin

In a growing trend among states, South Dakota’s House of Representatives approved a proposal, 40-28, Monday to endorse ivermectin as an alternative therapy to COVID-19 vaccines.  The lower state legislative chamber voted to advance House Bill 1267,...

read more
Page 1 of 1112345…10…»Last »

Address:

Commonweal P.O Box 316 | Bolinas, CA 94924

Latest Covid news in your inbox!

Success!

Subscribe

Search Articles

©2021 CovidStrategies/Commonweal | Site maintained by Mercury Multimedia

Privacy Policy | Home